Juniper Pharmaceuticals Inc logo

JNP - Juniper Pharmaceuticals Inc News Story

$11.5 0.0  0.0%

Last Trade - 13/08/18

Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £40.0m
Position in Universe th / 6849

BRIEF-Juniper Pharmaceuticals reports third quarter results

Thu 2nd November, 2017 8:05pm
Nov 2 (Reuters) - Juniper Pharmaceuticals Inc  JNP.O  
    * Juniper Pharmaceuticals reports third quarter 2017 
financial and 
operating results 
    * Q3 loss per share $0.13 
    * Q3 revenue rose 12 percent to $13 million 
Source text for Eikon:  ID:nPn82P1Xka  
Further company coverage:  JNP.O  
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.